| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |